Le Lézard
Classified in: Ebola virus, Health, Science and technology, Covid-19 virus
Subject: Dividend

Merck Announces Fourth-Quarter 2021 Dividend


Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Board of Directors has declared a quarterly dividend of $0.65 per share of the company's common stock for the fourth quarter of 2021. Payment will be made on October 7, 2021 to shareholders of record at the close of business on September 15, 2021.

About Merck

For 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals ? including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases ? as we aspire to be the premier research-intensive biopharmaceutical company in the world. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn.

Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA

This news release of Merck & Co., Inc., Kenilworth, N.J., USA (the "company") includes "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company's management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company's 2020 Annual Report on Form 10-K and the company's other filings with the Securities and Exchange Commission (SEC) available at the SEC's Internet site (www.sec.gov).


These press releases may also interest you

at 20:30
??Cato Networks, provider of the world's first SASE platform, announced today that SecureCraft Pte. Ltd. has joined Cato's channel partner program in Singapore and Malaysia. Leveraging its market expertise and existing network and channel outreach,...

at 20:05
Kong Inc., the cloud connectivity company, today announced the winners of its inaugural Cloud Connectivity Innovator Awards program at Kong Summit 2021. The awards recognize individuals and teams who have accelerated digital transformation during the...

at 20:05
Information Services Group (ISG) , a leading global technology research and advisory firm, announced today it has earned "Great Place to Work Certificationtm" by the Great Place to Work® Institute. ISG Australia was certified this month based on the...

at 20:05
KuCoin, a global leading crypto exchange, is thrilled to announce the launch of KuCoin Crypto Friday, which is the Black Friday for cryptocurrency holders. The event is scheduled from September 29 to October 10, and it is going to give away a total...

at 20:00
Nanotech Security Corp. ("Nanotech" or the "Company"), a leader in the development of secure and visually memorable nano-optic security features used in the government and banknote and brand protection markets, is pleased to announce that, at its...

at 20:00
Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, released...



News published on 27 july 2021 at 13:35 and distributed by: